116th CONGRESS 2d Session |
Expressing support for designation of March 3, 2020, as National Triple-Negative Breast Cancer Day.
March 3, 2020
Mr. Morelle submitted the following resolution; which was referred to the Committee on Oversight and Reform
Expressing support for designation of March 3, 2020, as National Triple-Negative Breast Cancer Day.
Whereas triple-negative breast cancer was recognized as a distinct type of cancer in 2006;
Whereas triple-negative breast cancer disproportionately affects young women, Black and Hispanic women, and those with BRCA gene mutations;
Whereas triple-negative breast cancers are estrogen receptor-negative, progesterone receptor-negative, and HER2-negative, making them distinct from other breast cancers;
Whereas there is no targeted therapy for triple-negative breast cancers;
Whereas 10 to 20 percent of all breast cancer diagnoses are designated as triple-negative;
Whereas triple-negative breast cancer can be more aggressive and more likely to spread and recur;
Whereas triple-negative breast cancer accounts for around 25 percent of all deaths from breast cancer in the United States; and
Whereas March 3, 2020, would be an appropriate date to designate as National Triple-Negative Breast Cancer Day: Now, therefore, be it
Resolved,